BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zou MJ, Cheng G, Okamoto H, Hao XH, An F, Cui FD, Danjo K. Colon-specific drug delivery systems based on cyclodextrin prodrugs: In vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates. World J Gastroenterol 2005; 11(47): 7457-7460 [PMID: 16437716 DOI: 10.3748/wjg.v11.i47.7457]
URL: https://www.wjgnet.com/1007-9327/full/v11/i47/7457.htm
Number Citing Articles
1
Majid Y. Moridani. Prodrugs and Targeted DeliveryMethods and Principles in Medicinal Chemistry 2010; 47: 207 doi: 10.1002/9783527633166.ch9
2
Noemi Bognanni, Francesco Bellia, Graziella Vecchio. Cyclodextrin Polymers Functionalized with Histidine and Carcinine as Chelating Therapeutics for Copper DyshomeostasisChemMedChem 2023; 18(13) doi: 10.1002/cmdc.202300035
3
Paulo José Salústio, Patrícia Pontes, Claúdia Conduto, Inês Sanches, Catarina Carvalho, João Arrais, Helena M. Cabral Marques. Advanced Technologies for Oral Controlled Release: Cyclodextrins for Oral Controlled ReleaseAAPS PharmSciTech 2011; 12(4): 1276 doi: 10.1208/s12249-011-9690-2
4
Tamaki Takagi, Tomiyasu Arisawa, Kazumasa Yamamoto, Ichiro Hirata, Hiroshi Nakano, Makoto Sawada. IDENTIFICATION OF LIGANDS BINDING SPECIFICALLY TO INFLAMMATORY INTESTINAL MUCOSA USING PHAGE DISPLAYClinical and Experimental Pharmacology and Physiology 2007; 34(4): 286 doi: 10.1111/j.1440-1681.2007.04563.x
5
Rajiv Sharma, Ravindra K. Rawal, Tripti Gaba, Nishu Singla, Manav Malhotra, Sahil Matharoo, T.R. Bhardwaj. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agentsBioorganic & Medicinal Chemistry Letters 2013; 23(19): 5332 doi: 10.1016/j.bmcl.2013.07.059
6
Angel Concheiro, Carmen Alvarez-Lorenzo. Chemically cross-linked and grafted cyclodextrin hydrogels: From nanostructures to drug-eluting medical devicesAdvanced Drug Delivery Reviews 2013; 65(9): 1188 doi: 10.1016/j.addr.2013.04.015
7
Sahil Kumar, Bandna Sharma, Tilak R. Bhardwaj, Rajesh K. Singh. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug DeliveryAnti-Cancer Agents in Medicinal Chemistry 2021; 21(3): 383 doi: 10.2174/1871520620666200811124013
8
Hossein Shahdadi Sardo, Farinaz Saremnejad, Sara Bagheri, Abbas Akhgari, Hadi Afrasiabi Garekani, Fatemeh Sadeghi. A review on 5-aminosalicylic acid colon-targeted oral drug delivery systemsInternational Journal of Pharmaceutics 2019; 558: 367 doi: 10.1016/j.ijpharm.2019.01.022
9
C.A. Schoener, N.A. Peppas. Oral delivery of chemotherapeutic agents: background and potential of drug delivery systems for colon deliveryJournal of Drug Delivery Science and Technology 2012; 22(6): 459 doi: 10.1016/S1773-2247(12)50081-X
10
Manish Dhall, A. K. Madan. Comparison of cyclodextrins and urea as hosts for inclusion of drugsJournal of Inclusion Phenomena and Macrocyclic Chemistry 2017; 89(3-4): 207 doi: 10.1007/s10847-017-0748-y
11
Stefano Salmaso, Fabio Sonvico. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine2011; : 251 doi: 10.1002/9780470926819.ch13
12
Zahra Vaezi, Shaghayegh Baradaran Ghavami, Maryam Farmani, Reza Mahdavian, Hamid Asadzadeh Aghdaei, Hossein Naderi-Manesh. Oral Formulation of 5-Aminosalicylic Acid-Hemoglobin Bio-Adhesive Nanoparticles Enhance Therapeutic Efficiency in Ulcerative Colitis Mice: A Preclinical EvaluationJournal of Pharmaceutical Sciences 2024; 113(8): 2331 doi: 10.1016/j.xphs.2024.03.028
13
Steven Neau. Water-Insoluble Drug Formulation, Second Edition2008; : 437 doi: 10.1201/9781420009552.ch16
14
Yanhong Wu, Shangyong Li, Mengfei Jin, Dandan Li, Zihan Zhou, Haiqing Hou, Yantao Han. Preparation of MSZ Hydrogel and Its Treatment of ColitisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.706401
15
Christian Lautenschläger, Carsten Schmidt, Dagmar Fischer, Andreas Stallmach. Drug delivery strategies in the therapy of inflammatory bowel diseaseAdvanced Drug Delivery Reviews 2014; 71: 58 doi: 10.1016/j.addr.2013.10.001
16
Hamid A. Bakshi, Gerry A. Quinn, Alaa A. A. Aljabali, Faruck L. Hakkim, Rabia Farzand, Mohamed M. Nasef, Naji Abuglela, Prawej Ansari, Vijay Mishra, Ángel Serrano-Aroca, Murtaza M. Tambuwala. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the ColonPharmaceuticals 2021; 14(12): 1211 doi: 10.3390/ph14121211
17
Mengchi Sun, Weiyue Ban, Hao Ling, Xiang Yu, Zhonggui He, Qikun Jiang, Jin Sun. Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel diseaseChinese Chemical Letters 2022; 33(10): 4449 doi: 10.1016/j.cclet.2022.03.061
18
Hui Min Chu, Rui Xia Zhang, Qing Huang, Chang Cai Bai, Zhi Zhong Wang. Chemical conjugation with cyclodextrins as a versatile tool for drug deliveryJournal of Inclusion Phenomena and Macrocyclic Chemistry 2017; 89(1-2): 29 doi: 10.1007/s10847-017-0743-3
19
Amal H. El-Kamel, Alaa A.-M. Abdel-Aziz, Amal J. Fatani, Hussein I. El-Subbagh. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: Synthesis, in vitro and in vivo assessmentInternational Journal of Pharmaceutics 2008; 358(1-2): 248 doi: 10.1016/j.ijpharm.2008.04.021
20
Francesco Bellia, Diego La Mendola, Carlo Pedone, Enrico Rizzarelli, Michele Saviano, Graziella Vecchio. Selectively functionalized cyclodextrins and their metal complexesChemical Society Reviews 2009; 38(9): 2756 doi: 10.1039/b718436k